Anticoagulation in COVID-19
NP Juffermans, MC Muller - The Coagulation Labyrinth of Covid-19, 2022 - Springer
Thrombotic complications in COVID-19 are highest in the most sick patients, reflecting
inflammatory driven pathways. Hospitalized patients should receive thromboprophylaxis, but …
inflammatory driven pathways. Hospitalized patients should receive thromboprophylaxis, but …
Anticoagulation in COVID-19 11
NP Juffermans, MC Muller - The Coagulation Labyrinth of Covid …, 2021 - books.google.com
The high incidence of thrombosis in patients with COVID-19 as well as the observation that
thrombotic complications or high D-dimer levels are associated with adverse outcomes [1] …
thrombotic complications or high D-dimer levels are associated with adverse outcomes [1] …
Anticoagulation in COVID-19
NP Juffermans, MC Muller - … of Covid-19, 2021 - researchinformation.amsterdamumc …
Thrombotic complications in COVID-19 are highest in the most sick patients, reflecting
inflammatory driven pathways. Hospitalized patients should receive thromboprophylaxis, but …
inflammatory driven pathways. Hospitalized patients should receive thromboprophylaxis, but …